These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 9166548)

  • 1. Progress in unresectable stage III non-small cell lung cancer.
    Vokes EE
    Cancer J Sci Am; 1996; 2(6):304-6. PubMed ID: 9166548
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase I trial of radiation with concurrent and consolidation pemetrexed and cisplatin in patients with unresectable stage IIIA/B non-small-cell lung cancer.
    Brade A; Bezjak A; MacRae R; Laurie S; Sun A; Cho J; Leighl N; Pearson S; Southwood B; Wang L; McGill S; Iscoe N; Shepherd FA
    Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1395-401. PubMed ID: 20605367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stage III nonsmall cell lung cancer: still a challenge for the radiation oncologist.
    Van Houtte P
    Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):533-5. PubMed ID: 9336128
    [No Abstract]   [Full Text] [Related]  

  • 4. Sequential platinum-based chemotherapy-thoracic radiotherapy in early stage non-small cell lung cancer.
    Thatcher N; Faivre-Finn C; Blackhall F; Anderson H; Lorigan P
    Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5051s-5056s. PubMed ID: 16000613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unresectable stage III non-small-cell lung cancer: lessons and directions from clinical trials research.
    Green MR
    J Natl Cancer Inst; 1991 Mar; 83(6):382-3. PubMed ID: 1847976
    [No Abstract]   [Full Text] [Related]  

  • 6. Concurrent chemoradiation in unresectable stage III non-small cell lung cancer: too much pain for no gain.
    Dillman RO
    Cancer J Sci Am; 1996; 2(2):76-8. PubMed ID: 9166503
    [No Abstract]   [Full Text] [Related]  

  • 7. Accelerated-interrupted radiation therapy given concurrently with chemotherapy for locally advanced non-small cell lung cancer.
    Ajlouni M; Chapman R; Kim JH
    Cancer J Sci Am; 1996; 2(6):314-20. PubMed ID: 9166551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy in stage III non-small cell lung cancer.
    Eberhardt WE; Hepp R
    Eur J Cancer; 2009 Sep; 45 Suppl 1():126-36. PubMed ID: 19775611
    [No Abstract]   [Full Text] [Related]  

  • 9. Phase I/II trial of biweekly docetaxel and cisplatin with concurrent thoracic radiation for stage III non-small-cell lung cancer.
    Iwasaki Y; Ohsugi S; Natsuhara A; Tsubokura T; Harada H; Ueda M; Arimoto T; Hara H; Yamada T; Takesako T; Kohno K; Hosogi S; Nakanishi M; Marunaka Y; Nishimura T
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):735-41. PubMed ID: 16565832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase III study of the Eastern Cooperative Oncology Group (ECOG 2597): induction chemotherapy followed by either standard thoracic radiotherapy or hyperfractionated accelerated radiotherapy for patients with unresectable stage IIIA and B non-small-cell lung cancer.
    Belani CP; Wang W; Johnson DH; Wagner H; Schiller J; Veeder M; Mehta M;
    J Clin Oncol; 2005 Jun; 23(16):3760-7. PubMed ID: 15837967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival is better predicted with a new classification of stage III unresectable non-small cell lung carcinoma treated by chemotherapy and radiotherapy.
    Berghmans T; Lafitte JJ; Thiriaux J; VanHoutte P; Lecomte J; Efremidis A; Koumakis G; Giner V; Richez M; Corhay JL; Wackenier P; Lothaire P; Mommen P; Ninane V; Sculier JP;
    Lung Cancer; 2004 Sep; 45(3):339-48. PubMed ID: 15301874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Management of non-small-cell lung carcinoma (NSCLC) of stage III B].
    Koukourakis M
    Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S33-6. PubMed ID: 11924241
    [No Abstract]   [Full Text] [Related]  

  • 13. [Concurrent chemoradiotherapy using a single agent for unresectable stage III non-small cell lung cancer].
    Tamura A; Mikami A; Sagara Y; Hebisawa A
    Gan To Kagaku Ryoho; 2000 Oct; 27(11):1755-8. PubMed ID: 11057330
    [No Abstract]   [Full Text] [Related]  

  • 14. [Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesin and cisplatin in unresectable stage III non small-cell lung cancer].
    Renard A; Noël G; Mazeron JJ
    Cancer Radiother; 2000; 4(4):317-8. PubMed ID: 10994396
    [No Abstract]   [Full Text] [Related]  

  • 15. Reply: Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small cell lung cancer.
    Van Meerbeeck JP; Van Schil PE; Senan S;
    J Thorac Oncol; 2007 Dec; 2(12):1138-9. PubMed ID: 18090593
    [No Abstract]   [Full Text] [Related]  

  • 16. Persistence of viable tumor cells after radiation and chemotherapy for stage IIIB non-small cell lung cancer: an early marker of treatment failure.
    Andre F; Grunewald D; Le Chevalier T
    J Thorac Cardiovasc Surg; 2001 Feb; 121(2):403. PubMed ID: 11174760
    [No Abstract]   [Full Text] [Related]  

  • 17. [Concurrent chemoradiotherapy for stage III non-small cell lung cancer].
    Hou HL; Hao JL; Pang QS; Wang P
    Zhonghua Yi Xue Za Zhi; 2010 Aug; 90(29):2068-70. PubMed ID: 21029648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oesophageal toxicity and hypofractionated concurrent chemoradiotherapy for non-small cell lung cancer.
    Tho LM; Mahmood R; Leitch M; Brisbane I; Kakumanu S; Mohammed N
    Clin Oncol (R Coll Radiol); 2009 Feb; 21(1):74. PubMed ID: 18986800
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapeutic management of non-small-cell lung carcinoma (NSCLC) of stage III A].
    Mornex F
    Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S29-32. PubMed ID: 11924239
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of unresectable non-small cell carcinoma of the lung (NSCLC).
    Cox JD; Le Chevalier T; Arriagada R; Choy H; Curran WJ; Fukuoka M; Harper P; Komaki R; Le Pechoux C; Lievens Y; Rami-Porta R; Ready N; Sause W; Stuschke M; Thatcher N
    Lung Cancer; 2003 Dec; 42 Suppl 1():S15-6. PubMed ID: 14708518
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.